News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
409,722 Results
Type
Article (21844)
Company Profile (135)
Press Release (387743)
Multimedia
Podcasts (73)
Webinars (11)
Section
Business (126287)
Career Advice (978)
Deals (23797)
Drug Delivery (99)
Drug Development (58276)
Employer Resources (89)
FDA (11745)
Job Trends (9369)
News (223899)
Policy (20810)
Tag
Academia (946)
Accelerated approval (3)
Adcomms (17)
Allergies (54)
Alliances (31537)
ALS (65)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (101)
Approvals (11749)
Artificial intelligence (176)
Autoimmune disease (19)
Automation (6)
Bankruptcy (227)
Best Places to Work (7050)
BIOSECURE Act (14)
Biosimilars (100)
Biotechnology (60)
Bladder cancer (63)
Brain cancer (20)
Breast cancer (167)
Cancer (1494)
Cardiovascular disease (132)
Career advice (801)
Career pathing (22)
CAR-T (78)
Cell therapy (228)
Cervical cancer (7)
Clinical research (48769)
Collaboration (572)
Compensation (247)
Complete response letters (24)
COVID-19 (1417)
CRISPR (27)
C-suite (176)
Cystic fibrosis (67)
Data (1576)
Decentralized trials (2)
Denatured (18)
Depression (28)
Diabetes (194)
Diagnostics (3128)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (23)
Drug discovery (88)
Drug pricing (115)
Drug shortages (30)
Duchenne muscular dystrophy (69)
Earnings (52185)
Editorial (32)
Employer branding (13)
Employer resources (82)
Events (59567)
Executive appointments (529)
FDA (12662)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (403)
Gene editing (63)
Generative AI (19)
Gene therapy (183)
GLP-1 (626)
Government (2166)
Grass and pollen (3)
Guidances (54)
Healthcare (8554)
Huntington's disease (14)
IgA nephropathy (21)
Immunology and inflammation (95)
Indications (21)
Infectious disease (1520)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (33)
Intellectual property (78)
Interviews (135)
IPO (10391)
IRA (45)
Job creations (2632)
Job search strategy (716)
Kidney cancer (8)
Labor market (24)
Layoffs (295)
Leadership (16)
Legal (4769)
Liver cancer (42)
Lung cancer (214)
Lymphoma (116)
Machine learning (3)
Management (34)
Manufacturing (244)
MASH (60)
Medical device (5833)
Medtech (5836)
Mergers & acquisitions (13828)
Metabolic disorders (585)
Multiple sclerosis (60)
NASH (20)
Neurodegenerative disease (59)
Neuropsychiatric disorders (25)
Neuroscience (1225)
NextGen: Class of 2025 (3081)
Non-profit (1161)
Now hiring (22)
Obesity (338)
Opinion (192)
Ovarian cancer (48)
Pain (84)
Pancreatic cancer (48)
Parkinson's disease (117)
Partnered (11)
Patents (198)
Patient recruitment (65)
Peanut (24)
People (37431)
Pharmaceutical (75)
Pharmacy benefit managers (21)
Phase I (15191)
Phase II (20978)
Phase III (16538)
Pipeline (979)
Policy (129)
Postmarket research (1746)
Preclinical (5558)
Press Release (29)
Prostate cancer (78)
Psychedelics (19)
Radiopharmaceuticals (175)
Rare diseases (283)
Real estate (3508)
Recruiting (31)
Regulatory (15318)
Reports (24)
Research institute (988)
Resumes & cover letters (153)
Rett syndrome (4)
RNA editing (3)
RSV (31)
Schizophrenia (65)
Series A (69)
Series B (42)
Service/supplier (8)
Sickle cell disease (41)
Special edition (16)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2187)
State (2)
Stomach cancer (9)
Supply chain (62)
Tariffs (44)
The Weekly (53)
Vaccines (358)
Venture capitalists (30)
Weight loss (252)
Women's health (19)
Worklife (8)
Date
Today (22)
Last 7 days (539)
Last 30 days (1660)
Last 365 days (21767)
2025 (7278)
2024 (23325)
2023 (25954)
2022 (32892)
2021 (33796)
2020 (31609)
2019 (24804)
2018 (19242)
2017 (21194)
2016 (19384)
2015 (23066)
2014 (17814)
2013 (14646)
2012 (15719)
2011 (16143)
2010 (14855)
Location
Africa (449)
Alabama (38)
Alaska (2)
Arizona (83)
Arkansas (9)
Asia (27093)
Australia (3726)
California (3786)
Canada (1255)
China (359)
Colorado (175)
Connecticut (163)
Delaware (100)
Europe (57144)
Florida (631)
Georgia (120)
Idaho (17)
Illinois (332)
India (23)
Indiana (224)
Iowa (3)
Japan (134)
Kansas (71)
Kentucky (19)
Louisiana (3)
Maine (41)
Maryland (567)
Massachusetts (2921)
Michigan (94)
Minnesota (215)
Mississippi (2)
Missouri (37)
Montana (17)
Nebraska (12)
Nevada (43)
New Hampshire (26)
New Jersey (1299)
New Mexico (21)
New York (1167)
North Carolina (670)
North Dakota (3)
Northern California (1590)
Ohio (130)
Oklahoma (5)
Oregon (22)
Pennsylvania (896)
Puerto Rico (12)
Rhode Island (22)
South America (655)
South Carolina (15)
Southern California (1533)
Tennessee (50)
Texas (604)
United States (14850)
Utah (126)
Virginia (114)
Washington D.C. (47)
Washington State (342)
West Virginia (2)
Wisconsin (39)
409,722 Results for "solasia pharma k k".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Biosimilars Shouldn’t Be This Hard To Bring to Market
Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of branded biologics looking to maintain blockbuster revenue.
March 24, 2025
·
7 min read
·
Sarfaraz K. Niazi
Deals
Lilly Drops Up to $2.5B for Scorpion’s PI3K-inhibitor Molecule
The multi-billion deal, in which Eli Lilly will acquire Scorpion Therapeutics’ STX-478 program, is a shot in the arm for PI3K treatments, which have had a mixed history over the past few years.
January 13, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
April 23, 2025
·
3 min read
Press Releases
BeyondSpring Files 2024 Annual Report on Form 10-K
March 28, 2025
·
2 min read
Press Releases
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
April 30, 2025
·
4 min read
Press Releases
Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K
March 19, 2025
·
2 min read
Press Releases
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
April 11, 2025
·
2 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer
April 11, 2025
·
3 min read
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
1 of 40,973
Next
